These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management. Witteles RM; Liedtke M JACC CardioOncol; 2019 Sep; 1(1):117-130. PubMed ID: 34396169 [TBL] [Abstract][Full Text] [Related]
5. AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: Bianchi G; Zhang Y; Comenzo RL JACC CardioOncol; 2021 Oct; 3(4):467-487. PubMed ID: 34729520 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment. Gertz MA Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145 [TBL] [Abstract][Full Text] [Related]
13. Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis. Zhang KW; Stockerl-Goldstein KE; Lenihan DJ JACC Basic Transl Sci; 2019 Jun; 4(3):438-448. PubMed ID: 31312767 [TBL] [Abstract][Full Text] [Related]
14. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis]. Cui Q; Yu J; Shen W Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045 [TBL] [Abstract][Full Text] [Related]
15. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist. Papathanasiou M; Carpinteiro A; Rischpler C; Hagenacker T; Rassaf T; Luedike P Int J Cardiol Heart Vasc; 2020 Jun; 28():100519. PubMed ID: 32373710 [TBL] [Abstract][Full Text] [Related]
16. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis. Cai S; Haghbayan H; Chan KKW; Deva DP; Jimenez-Juan L; Connelly KA; Ng MY; Yan RT; Yan AT Int J Cardiol; 2024 May; 403():131892. PubMed ID: 38382853 [TBL] [Abstract][Full Text] [Related]
17. Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient. Vergaro G; Castiglione V; Poletti R; Buda G; Pucci A; Musetti V; Genovesi D; Aimo A; Passino C; Emdin M JACC Case Rep; 2021 Mar; 3(3):450-454. PubMed ID: 34317556 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved. Al Saleh AS; Sidiqi MH; Muchtar E; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA Biol Blood Marrow Transplant; 2019 Aug; 25(8):1520-1525. PubMed ID: 31054986 [TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment. Gertz MA Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896 [TBL] [Abstract][Full Text] [Related]
20. Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial. Shen KN; Fu WJ; Wu Y; Dong YJ; Huang ZX; Wei YQ; Li CR; Sun CY; Chen Y; Miao HL; Zhang YL; Cao XX; Zhou DB; Li J Circulation; 2022 Jan; 145(1):8-17. PubMed ID: 34503349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]